- Home
- RRBI vs ATXS Comparison
RRBI vs ATXS Comparison
Compare RRBI & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- ATXS
- Stock Information
- Founded
- RRBI 1998
- ATXS 2008
- Country
- RRBI United States
- ATXS United States
- Employees
- RRBI N/A
- ATXS N/A
- Industry
- RRBI Hotels/Resorts
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- RRBI Consumer Discretionary
- ATXS Health Care
- Exchange
- RRBI Nasdaq
- ATXS Nasdaq
- Market Cap
- RRBI 341.1M
- ATXS 401.2M
- IPO Year
- RRBI 2019
- ATXS 2015
- Fundamental
- Price
- RRBI $55.13
- ATXS $4.23
- Analyst Decision
- RRBI Buy
- ATXS Strong Buy
- Analyst Count
- RRBI 1
- ATXS 6
- Target Price
- RRBI $62.00
- ATXS $30.00
- AVG Volume (30 Days)
- RRBI 6.0K
- ATXS 498.3K
- Earning Date
- RRBI 04-30-2025
- ATXS 05-20-2025
- Dividend Yield
- RRBI 0.86%
- ATXS N/A
- EPS Growth
- RRBI 13.23
- ATXS N/A
- EPS
- RRBI 5.31
- ATXS N/A
- Revenue
- RRBI $112,121,000.00
- ATXS N/A
- Revenue This Year
- RRBI N/A
- ATXS N/A
- Revenue Next Year
- RRBI $5.90
- ATXS N/A
- P/E Ratio
- RRBI $10.46
- ATXS N/A
- Revenue Growth
- RRBI 6.22
- ATXS N/A
- 52 Week Low
- RRBI $42.78
- ATXS $3.56
- 52 Week High
- RRBI $62.13
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- RRBI 62.54
- ATXS 36.98
- Support Level
- RRBI $53.55
- ATXS $5.01
- Resistance Level
- RRBI $53.00
- ATXS $5.47
- Average True Range (ATR)
- RRBI 1.22
- ATXS 0.39
- MACD
- RRBI 0.57
- ATXS -0.01
- Stochastic Oscillator
- RRBI 90.12
- ATXS 7.81
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.